A user-friendly and scalable process to prepare a ready-to-use inactivated vaccine: the example of heartwater in ruminants under tropical conditions.

[1]  N. Vachiéry,et al.  Opportunities in diagnostic and vaccine approaches to mitigate potential heartwater spreading and impact on the American mainland. , 2013, Developments in biologicals.

[2]  P. Alves,et al.  Proteomic analyses of Ehrlichia ruminantium highlight differential expression of MAP1-family proteins. , 2012, Veterinary microbiology.

[3]  D. Meyer,et al.  A new typing technique for the Rickettsiales Ehrlichia ruminantium: multiple-locus variable number tandem repeat analysis. , 2012, Journal of microbiological methods.

[4]  Chunhe Wan,et al.  Evaluation of several adjuvants in avian influenza vaccine to chickens and ducks , 2011, Virology Journal.

[5]  P. Alves,et al.  Efficiency of inactivated vaccines against heartwater in Burkina Faso: impact of Ehrlichia ruminantium genetic diversity. , 2010, Vaccine.

[6]  D. Meyer,et al.  Mining the genetic diversity of Ehrlichia ruminantium using map genes family. , 2010, Veterinary parasitology.

[7]  B. Allsopp.  Natural history of Ehrlichia ruminantium. , 2010, Veterinary parasitology.

[8]  H. Vordermeier,et al.  Adjuvants Induce Distinct Immunological Phenotypes in a Bovine Tuberculosis Vaccine Model , 2009, Clinical and Vaccine Immunology.

[9]  N. Collins,et al.  A heterologous prime/boost immunisation strategy protects against virulent E. ruminantium Welgevonden needle challenge but not against tick challenge. , 2008, Vaccine.

[10]  P. Alves,et al.  Immunisation of sheep against heartwater in The Gambia using inactivated and attenuated Ehrlichia ruminantium vaccines. , 2007, Vaccine.

[11]  P. Alves,et al.  Effect of the purification process and the storage conditions on the efficacy of an inactivated vaccine against heartwater. , 2007, Vaccine.

[12]  N. Collins,et al.  Protection against heartwater by DNA immunisation with four Ehrlichia ruminantium open reading frames. , 2007, Vaccine.

[13]  H. C. Steyna,et al.  Protection against heartwater by DNA immunisation with four Ehrlichia ruminantium open reading frames , 2007 .

[14]  J. Weber,et al.  Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvant , 2006, Journal of Translational Medicine.

[15]  N. Vachiéry,et al.  Optimisation of the inactivated vaccine dose against heartwater and in vitro quantification of Ehrlichia ruminantium challenge material. , 2006, Vaccine.

[16]  P. Alves,et al.  Process development for the mass production of Ehrlichia ruminantium. , 2006, Vaccine.

[17]  A. Saul,et al.  Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations. , 2005, Vaccine.

[18]  V. Schijns,et al.  Structure-activity relations of water-in-oil vaccine formulations and induced antigen-specific antibody responses. , 2005, Vaccine.

[19]  A. Saul,et al.  Extraction and characterization of vaccine antigens from water-in-oil adjuvant formulations. , 2005, Methods in molecular biology.

[20]  P. Piccerelle,et al.  Texture Optimization of Water‐in‐Oil Emulsions , 2004, Pharmaceutical development and technology.

[21]  C. Teuscher,et al.  Genetic analysis of the influence of neuroantigen-complete Freund's adjuvant emulsion structures on the sexual dimorphism and susceptibility to experimental allergic encephalomyelitis. , 2003, The American journal of pathology.

[22]  Lieping Chen,et al.  A simple and rapid vortex method for preparing antigen/adjuvant emulsions for immunization. , 2003, Journal of immunological methods.

[23]  G. Smith,et al.  Reduction in mortality from heartwater in cattle, sheep and goats exposed to field challenge using an inactivated vaccine. , 2001, Veterinary parasitology.

[24]  S. Singh,et al.  Evaluation of three 'ready to formulate' oil adjuvants for foot-and-mouth disease vaccine production. , 2000, Vaccine.

[25]  A. Barbet,et al.  The inactivated Cowdria ruminantium vaccine for heartwater protects against heterologous strains and against laboratory and field tick challenge. , 1998, Vaccine.

[26]  E. Claassen,et al.  Immune responses and side effects of five different oil-based adjuvants in mice. , 1998, Veterinary immunology and immunopathology.

[27]  D. Martinez,et al.  Comparative efficacy of Freund's and Montanide ISA50 adjuvants for the immunisation of goats against heartwater with inactivated Cowdria ruminantium. , 1996, Veterinary parasitology.

[28]  D. Martinez,et al.  Use of a specific immunogenic region on the Cowdria ruminantium MAP1 protein in a serological assay , 1995, Journal of clinical microbiology.

[29]  D. Martinez,et al.  Protection of goats against heartwater acquired by immunisation with inactivated elementary bodies of Cowdria ruminantium. , 1994, Veterinary immunology and immunopathology.

[30]  G. Castrucci,et al.  Field evaluation of the efficacy of Romovac 50, a new inactivated, adjuvanted bovine rotavirus vaccine. , 1993, Comparative immunology, microbiology and infectious diseases.

[31]  Y. Israel,et al.  Simple method for the preparation of antigen emulsions for immunization. , 1993, Journal of immunological methods.

[32]  W. J. Herbert.  The mode of action of mineral-oil emulsion adjuvants on antibody production in mice. , 1968, Immunology.

[33]  U. Linne,et al.  Microalgae as bioreactors for bioplastic production , 2011, Microbial cell factories.